NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LYMPHATIC EDUCATION & RESEARCH NETWORK INC (LE&RN), founded in 1998, is a community nonprofit in the Medical Research sector that reported $1.3M in total revenue in fiscal year 2025. Revenue fell 27% from the prior year — a significant decline worth monitoring. Expenses of $1.8M exceeded revenue, resulting in a 38% operating deficit.
THE ORGANIZATION'S MISSION IS TO FIGHT LYMPHATIC DISEASES AND LYMPHEDEMA THROUGH EDUCATION, RESEARCH AND ADVOCACY. THE ORGANIZATION SEEKS TO ACCELERATE THE PREVENTION, TREATMENT, AND CURE OF LYMPHATIC DISEASES WHILE BRINGING PATIENTS AND MEDICAL PROFESSIONALS TOGETHER TO ADDRESS THE UNMET NEEDS SURROUNDING LYMPHATIC DISORDERS.
Some activities of the organization during 2025 include the following: LE&RN continued to expand programs to meet the goals of the expanded mission of fighting lymphatic disease through education...
Some activities of the organization during 2025 include the following: LE&RN continued to expand programs to meet the goals of the expanded mission of fighting lymphatic disease through education, research, and advocacy. LE&RN continued its grant program, which allows young investigators to attend conferences focused on lymphatic research. LE&RN continued its educational and awareness outreach programs targeting academia, government, industry, and the medical and patient communities. LE&RN continued its monthly virtual symposium series, which brings the world's foremost authorities in lymphatic disease and lymphedema to patients, their families, and professionals. LE&RN updated its website and provided daily social media posts and monthly newsletters featuring significant events in the field. LE&RN produced six issues of Lymphatic Research and Biology, an international, peer-reviewedbiomedical journal providing a forum for the exchange of cutting-edge scientific developments in lymphatic science and medicine. LE&RN secured ongoing support from the Congressional and National Institutes of Health for lymphatic research. LE&RN continued the LE&RN/LymphNotes Lymphedema Scholarship Program to provide tuition support to therapists seeking certification in lymphedema therapy. LE&RN continued a web-based "Ask the Experts" feature that allows patients, their families, and professionals to ask the most prominent authorities in the field questions directly. LE&RN spokesperson and Academy Award Winner Kathy Bates appeared in print and television media to support research. LE&RN's Virtual Expo was expanded to better serve patients and therapists. LE&RN and NAVBO prepared a biennial Virtual Lymphatic Forum for researchers LE&RN developed new chapters in several states and countries. LE&RN continued to lead global events related to its establishment of World Lymphedema Day on March 6, 2016. LE&RN supported and grew its Centers of Excellence in the Diagnosis & Treatment of Lymphatic Diseases to 80 member institutions in over 20 countries. LE&RN, in collaboration with Stanford University, hosted the annual virtual State-of-the-Art Summit in Lymphatic Research & Medicine. LE&RN promoted its PSA video featuring National Spokesperson Kathy Bates, which was hosted on the Centers for Disease Control and Prevention (CDC) 's cancer-related websites. LE&RN continued its cancer-related lymphedema campaign. LE&RN succeeded in having the Congressionally Directed Medical Research Program (CDMRP) include lymphedema as a category in the Department of Defense's Peer Reviewed Medical Research Program (PRMRP). LE&RN successfully requested that Congress establish a National Commission on Lymphatic Diseases at the National Institutes of Health (NIH). LE&RN established a global Patient Resource Center. LE&RN expanded and updated its Global Patient Registry. LE&RN successfully advocated for a Program Manager in Lymphatics at the Advanced Research Agency for Health (ARPA-H) LE&RN, in concert with the research community, created a "Gaps in Lymphatic Research" document that was distributed to the NIH, CDC, ARPA-H, CDMRP, NNLBI, and NIAID. LE&RN hired its first full-time Vice President of Scientific Affairs and Science and Medical Director.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $1,283,221 | $1,755,810 | -0.3% |
| Expenses | $1,770,505 | $1,651,386 | +0.1% |
| Net Income | $-487,284 | $104,424 | -5.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JOSEPH DAYAN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Dr Emily Iker | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MELISSA ALDRICH PHD | CHAIRPERSON | 10.00 |
Officer
Director
|
$0 | $0 | $0 |
| RICK PETTY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Liz Basaca | TREASURER | 1.00 |
Director
|
$0 | $0 | $0 |
| DORON ILAN MD | SECRETARY | 1.00 |
Director
|
$0 | $0 | $0 |
| Jonathan Ross | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| WILLIAM REPICCI | PRESIDENT & CEO | 40.00 |
Officer
|
$314,640 | $57,767 | $372,407 |
| Maria Celia Dupecher | Vice President for Scientific Affairs | 40.00 |
Highest
|
$146,250 | $0 | $146,250 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $1,283,221 | $1,770,505 | $3,590,003 | $-487,284 |
| 2025 | $1,283,221 | $1,770,505 | $3,590,003 | $-487,284 |
| 2024 | $1,755,810 | $1,651,386 | $4,009,793 | $104,424 |
| 2023 | $1,476,365 | $1,736,198 | $3,828,174 | $-259,833 |
| 2022 | $1,462,533 | $1,490,145 | $3,910,350 | $-27,612 |
| 2021 | $4,129,686 | $997,532 | $3,889,093 | $3,132,154 |
| 2020 | $894,003 | $731,503 | $654,052 | $162,500 |
| 2019 | $1,001,853 | $866,648 | $501,469 | $135,205 |
| 2018 | $912,615 | $867,921 | $352,714 | $44,694 |
Compare LYMPHATIC EDUCATION & RESEARCH NETWORK INC (LE&RN) with other nonprofits in New York and across the country.